Your browser doesn't support javascript.
loading
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial.
Middleton, Gary; Silcocks, Paul; Cox, Trevor; Valle, Juan; Wadsley, Jonathan; Propper, David; Coxon, Fareeda; Ross, Paul; Madhusudan, Srinivasan; Roques, Tom; Cunningham, David; Falk, Stephen; Wadd, Nick; Harrison, Mark; Corrie, Pippa; Iveson, Tim; Robinson, Angus; McAdam, Karen; Eatock, Martin; Evans, Jeff; Archer, Caroline; Hickish, Tamas; Garcia-Alonso, Angel; Nicolson, Marianne; Steward, William; Anthoney, Alan; Greenhalf, William; Shaw, Victoria; Costello, Eithne; Naisbitt, Dean; Rawcliffe, Charlotte; Nanson, Gemma; Neoptolemos, John.
Afiliação
  • Middleton G; University of Birmingham, Edgbaston, Birmingham, UK.
  • Silcocks P; Liverpool Cancer Research UK Cancer Trials Unit and GCLP Facility, University of Liverpool, Liverpool, UK.
  • Cox T; Liverpool Cancer Research UK Cancer Trials Unit and GCLP Facility, University of Liverpool, Liverpool, UK.
  • Valle J; Manchester Academic Health Sciences Centre, Christie Hospital NHS Foundation Trust and University of Manchester, Manchester UK.
  • Wadsley J; Weston Park Hospital, Sheffield Teaching Hospital NHS Foundation Trust, Sheffield, UK.
  • Propper D; St Bartholomew's Hospital, Barts Health NHS Trust, West Smithfield, London, UK.
  • Coxon F; Northern Centre for Cancer Care, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Newcastle upon Tyne, UK.
  • Ross P; Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Madhusudan S; Nottingham City Hospital, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Roques T; Norfolk and Norwich University Hospital, Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, UK.
  • Cunningham D; The Royal Marsden, The Royal Marsden NHS Foundation Trust, London, UK.
  • Falk S; Bristol Haematology And Oncology Centre, University Hospital Bristol NHS Foundation Trust, Bristol, UK.
  • Wadd N; The James Cook University Hospital, South Tees Hospitals NHS Foundation Trust, Middleborough, UK.
  • Harrison M; Mount Vernon Hospital, The Hillingdon Hospitals NHS Foundation Trust, Northwood, UK.
  • Corrie P; Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Iveson T; Southampton General Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, UK.
  • Robinson A; Conquest Hospital, East Sussex Healthcare NHS Trust, The Ridge, St Leonards-on-Sea, East Sussex, UK.
  • McAdam K; Peterborough City Hospital, Peterborough and Stamford Hospitals NHS Foundation Trust, Edith, Cavell Campus, Peterborough, UK.
  • Eatock M; Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, UK.
  • Evans J; University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK.
  • Archer C; Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust, Cosham, Portsmouth, UK.
  • Hickish T; Royal Bournemouth Hospital, The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, Bournemouth, UK.
  • Garcia-Alonso A; Glan Clwyd Hospital, University Health Board, Rhyl, Denbighshire, UK.
  • Nicolson M; Abderdeen Royal Infirmary, NHS Grampian, Aberdeen, UK.
  • Steward W; Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK.
  • Anthoney A; St James University Hospital, The Leeds Teaching Hospital Trust, Beckett Street, Leeds, UK.
  • Greenhalf W; Liverpool Cancer Research UK Cancer Trials Unit and GCLP Facility, University of Liverpool, Liverpool, UK.
  • Shaw V; Liverpool Cancer Research UK Cancer Trials Unit and GCLP Facility, University of Liverpool, Liverpool, UK.
  • Costello E; Liverpool Cancer Research UK Cancer Trials Unit and GCLP Facility, University of Liverpool, Liverpool, UK.
  • Naisbitt D; Liverpool Cancer Research UK Cancer Trials Unit and GCLP Facility, University of Liverpool, Liverpool, UK.
  • Rawcliffe C; Liverpool Cancer Research UK Cancer Trials Unit and GCLP Facility, University of Liverpool, Liverpool, UK.
  • Nanson G; Liverpool Cancer Research UK Cancer Trials Unit and GCLP Facility, University of Liverpool, Liverpool, UK.
  • Neoptolemos J; Liverpool Cancer Research UK Cancer Trials Unit and GCLP Facility, University of Liverpool, Liverpool, UK. Electronic address: j.p.neoptolemos@liverpool.ac.uk.
Lancet Oncol ; 15(8): 829-40, 2014 Jul.
Article em En | MEDLINE | ID: mdl-24954781
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ductos Pancreáticos / Neoplasias Pancreáticas / Fragmentos de Peptídeos / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Telomerase / Vacinas Anticâncer Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ductos Pancreáticos / Neoplasias Pancreáticas / Fragmentos de Peptídeos / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Telomerase / Vacinas Anticâncer Idioma: En Ano de publicação: 2014 Tipo de documento: Article